Growth Metrics

Innoviva (INVA) Current Deferred Revenue (2016 - 2025)

Innoviva (INVA) has disclosed Current Deferred Revenue for 12 consecutive years, with $4.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Deferred Revenue rose 279.22% year-over-year to $4.3 million, compared with a TTM value of $4.3 million through Dec 2025, up 279.22%, and an annual FY2025 reading of $4.3 million, up 279.22% over the prior year.
  • Current Deferred Revenue was $4.3 million for Q4 2025 at Innoviva, down from $13.6 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $13.6 million in Q3 2025 and bottomed at $717000.0 in Q3 2024.
  • Average Current Deferred Revenue over 4 years is $2.8 million, with a median of $1.8 million recorded in 2022.
  • The sharpest move saw Current Deferred Revenue tumbled 73.72% in 2024, then skyrocketed 1792.75% in 2025.
  • Year by year, Current Deferred Revenue stood at $2.1 million in 2022, then crashed by 39.02% to $1.3 million in 2023, then dropped by 11.82% to $1.1 million in 2024, then skyrocketed by 279.22% to $4.3 million in 2025.
  • Business Quant data shows Current Deferred Revenue for INVA at $4.3 million in Q4 2025, $13.6 million in Q3 2025, and $3.1 million in Q2 2025.